The launch of the EU’s Critical Medicines Alliance, aimed at improving supplies of important medicines, could be the first step towards a Critical Medicines Act designed to support production of APIs and finished medicines in the EU. However, whether such an act is feasible remains uncertain.
Meanwhile, EFPIA, which represents the innovative pharmaceutical industry in Europe, has called on EU bodies to couple action on medicine supplies with ambitious steps to make the EU more
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?